Engineering Nanoparticles to Modulate Gut Microbiota in Obesity-Induced Insulin Resistance
Muhindo Anitah
Department of Pharmacy Kampala International University Uganda
Email: anitah.muhindo@studwc.kiu.ac.ug
ABSTRACT
Obesity-induced insulin resistance emerges from intertwined host–microbe interactions that reshape intestinal permeability, immune tone, and metabolic signaling. Dysbiosis, characterized by reduced microbial diversity, altered short-chain fatty acid production, perturbed bile acid pools, and increased endotoxin translocation, amplifies systemic inflammation and impairs insulin action. Conventional approaches—dietary fiber, probiotics, and antibiotics often show variable efficacy due to poor colon targeting, instability across the gastrointestinal tract, off-target effects, and person-to-person microbiome heterogeneity. Engineered nanoparticles offer a precision toolkit to tune the gut ecosystem and its crosstalk with the host. By co-optimizing materials, size, surface chemistry, and stimuli-responsive release, nanoparticles can protect labile cargos, navigate mucus and epithelial barriers, selectively deliver prebiotics, postbiotics, enzymes, microbial modulators, or gene editors to specific niches, and even sequester luminal toxins such as lipopolysaccharide. This review articulates design principles for gut-directed nanocarriers; examines strategies to enrich beneficial taxa and functions, attenuate pathobionts, and restore barrier integrity; and outlines theranostic systems that couple localized imaging with microbiota-targeted therapy. We evaluate safety, manufacturability, and regulatory considerations, and propose clinical trial frameworks integrating multi-omics, breath and plasma metabolomics, and continuous glucose monitoring. By aligning materials science with microbial ecology, nanoparticle platforms can convert microbiome modulation from broad-stroke interventions into targeted, durable, and metabolically meaningful therapy.
Keywords: gut microbiota; nanoparticles; dysbiosis; insulin resistance; obesity; short-chain fatty acids; bile acids; endotoxemia; mucus-penetrating particles; oral nanomedicine
CITE AS: Muhindo Anitah (2026). Engineering Nanoparticles to Modulate Gut Microbiota in Obesity-Induced Insulin Resistance. IAA Journal of Scientific Research 13(1):102-110.